SION
Sionna Therapeutics, Inc. Common Stock
NASDAQ: SION · HEALTHCARE · BIOTECHNOLOGY
$45.95
+3.89% today
Updated 2026-05-11
Market cap
$2.07B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.88
Dividend yield
—
52W range
$12 – $48
Volume
0.4M
Sionna Therapeutics, Inc. Common Stock (SION) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $87.37M | $51.95M | $185.75M |
| Cash & equivalents | $54.84M | $38.52M | $37.79M |
| Current assets | $83.83M | $39.21M | $150.99M |
| Total liabilities | $157.29M | $166.83M | $349.46M |
| Current liabilities | $8.25M | $8.04M | $10.42M |
| Long-term debt | — | — | — |
| Shareholder equity | $-69.92M | $-114.88M | $-163.71M |
| Retained earnings | $-72.14M | $-119.40M | $-181.09M |
| Accounts receivable | — | — | — |
| Inventory | — | — | — |
| Goodwill | — | — | — |